Theriva Biologics Inc
F:SFY
Shareholder Yield
Current shareholder yield for SFY is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
SFY Price
Theriva Biologics Inc
| Average Annual Return | -74.62% |
| Standard Deviation of Annual Returns | 8.82% |
| Max Drawdown | -100% |
| Market Capitalization | 7.6m EUR |
| Shares Outstanding | 17 277 400 |
| Percentage of Shares Shorted |
N/A
|
SFY Return Decomposition
Main factors of price return
Stock Splits
SFY's latest stock split occurred on Aug 26, 2024
The company executed a 1-for-25 stock split, meaning that for every 25 shares held, investors received 1 new share.
Before the split, SFY traded at 0.0968 per share. Afterward, the share price was about 2.42.
The adjusted shares began trading on Aug 26, 2024. This was SFY's 3rd stock split, following the previous one in Jul 25, 2022.
